Even as vaccinations across the U.S. were ramping up due to the popularity and availability of the one-dose Johnson & Johnson vaccine, the CDC called a timeout due to reports of serious blood clots
The vaccine passport is coming. The likelihood of a “passport” being required — or perhaps just requested — for travel, and to return to school and work, seems a certainty. New York state is testing a smartphone app that would verify vaccine status for entry into events. IBM is developing...
COVID-19 is far from beaten. Vaccines may not be the ultimate panacea to haul us out of the pandemic crisis. In the future, will outbreaks of SARS-CoV-2, the virus that causes COVID-19, arrive in waves every winter? Might COVID-19 never go away? Experts at the University of California, Riverside, weigh...
The news arrived Monday that the world has been awaiting since spring: a vaccine has been developed that shows a high degree of efficacy in late-stage trials: 90%. That puts it in the company of effective vaccines such as for measles, and well beyond what the medical community hoped for...
